The BEVETEX Judgment: Delhi High Court Emphasizes Caution in Cancer Drug Branding
The Delhi High Court recently delivered a significant judgment in a trademark infringement dispute between Sun Pharma Laboratories Limited and Intas Pharmaceuticals Limited, reaffirming the heightened standard of scrutiny applicable in pharmaceutical trademark cases. The dispute revolved around the plaintiff’s registered mark “BEVETEX” and the defendant’s use of the mark “BEVATAS”, both in relation to…
